Home › Funds › CAPITAL FUND MANAGEMENT S.A. › UTHR

CAPITAL FUND MANAGEMENT S.A. position in UTHR

UNITED THERAPEUTICS CORP DEL · Health Care

CAPITAL FUND MANAGEMENT S.A. reported holding 110,907 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q3 2026 13F filing — a position valued at US$60.1M, representing 0.65% of its reported portfolio and ranking #15 among its reported holdings. CAPITAL FUND MANAGEMENT S.A. has disclosed UTHR holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)110.91K sh
Reported value held$60.10M
Portfolio Weight0.65%
First reportedQ1 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CAPITAL FUND MANAGEMENT S.A.'s UTHR position evolved

CAPITAL FUND MANAGEMENT S.A. first disclosed a stake in UTHR in Q1 2024 at 18,389 shares (US$4.2M). The position peaked in Q3 2026 at 110,907 shares, worth US$60.1M. Across 11 filings, CAPITAL FUND MANAGEMENT S.A. increased the stake 8 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 110,907 shares valued at US$60.1M — an increase of 57,870 shares quarter over quarter.. Notable position changes include a 101% increase in Q2 2025 (shares rose 46% over the following quarter), a 52% trim in Q4 2025 (shares rose 22% over the following quarter), a 109% increase in Q3 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 18.39K $4.22M New
Q2 2024 23.52K $7.49M Add
Q3 2024 29.65K $10.63M Add
Q4 2024 40.23K $14.20M Add
Q1 2025 24.06K $7.42M Reduce
Q2 2025 48.48K $13.93M Add
Q3 2025 68.89K $28.88M Add
Q4 2025 33.36K $16.25M Reduce
Q1 2026 48.96K $29.03M Add
Q2 2026 53.04K $28.74M Add
Q3 2026 110.91K $60.10M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UTHR and 13F data

UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 39 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$908.2M), ASSETMARK, INC (US$325.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UTHR

All UTHR fund holders →

FAQ

How long has CAPITAL FUND MANAGEMENT S.A. held UTHR?

CAPITAL FUND MANAGEMENT S.A. has disclosed UTHR holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is CAPITAL FUND MANAGEMENT S.A.'s current position in UTHR?

As of Q3 2026, CAPITAL FUND MANAGEMENT S.A. holds 110.91K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $60.10M, representing 0.65% of its reported portfolio and ranking #15.

Has CAPITAL FUND MANAGEMENT S.A. been buying or selling UTHR?

In the latest 13F filing (Q3 2026), CAPITAL FUND MANAGEMENT S.A. increased its position in UTHR. The position peaked in Q3 2026 at 110.91K shares.

Which other funds hold UTHR?

Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.